Moreover, PD-L1 expression elevated with an increase in TIL abundance within the endometrial tumor microenvironment, suggesting that PD-1 inhibitors could trigger a potent anti-tumor immune response due to the high PD-L1 expression [41, 42]. Here, CD274 is linked to neoplasm.